Serena Quattrucci

Serena Quattrucci

Auto-generated profile, based on publicly available information

Serena Quattrucci

Department of Pediatrics, Sapienza University of Rome, I‑00161 Rome, Italy

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2021 in Experimental and Therapeutic Medicine
Verified
Journal Article
Open access
PDF file
MPMaria Pelullo
Maria Pelullo
DSDaniela Savi
Daniela Savi
SQSerena Quattrucci
Serena Quattrucci
GCGiuseppe Cimino
Giuseppe Cimino
APAntonio Pizzuti
Antonio Pizzuti
SCSamantha Cialfi
Samantha Cialfi
In the physiopathology of cystic fibrosis (CF), oxidative stress implications are recognized and widely accepted. The cystic fibrosis transmembrane conductance regulator (CFTR) defects disrupt the intracellular redox balance causing CF pathological hallmarks. Therefore, oxidative stress together with aberrant expression levels of detoxification genes and microRNAs (miRNAs/miRs) may be associated with clinical outcome. Using total RNA extracted from epithelial nasal cells, the present study analyzed the expression levels of oxidative stress genes and one miRNA using quantitative PCR in a representative number of patients with CF compared with in healthy individuals. The present pilot study revealed the existence of an association among CFTR, genes involved in the oxidative stress response and miR‑125b. The observed downregulation of CFTR gene expression was accompanied by increased expression levels of Nuclear factor erythroid derived‑2 like2 and its targets NAD(P)H:Quinone Oxidoreductase and glutathione S‑transferase 1. Moreover, the expression levels of heme oxygenase‑1 (HO‑1) and miR‑125b were positively correlated with a forced expiratory volume in 1 sec (FEV1) >60% in patients with CF with chronic Pseudomonas aeruginosa lung infection (r=0.74; P<0.001 and r=0.57; P<0.001, respectively). The present study revealed the activation of an inducible, but not fully functional, oxidative stress response to protect airway cells against reactive oxygen species‑dependent injury in CF disease. Additionally, the correlations of HO‑1 and miR‑125b expression with an improved FEV1 value suggested that these factors may synergistically protect the airway cells from oxidative stress damage, inflammation and apoptosis. Furthermore, HO‑1 and miR‑125b may be used as prognostic markers explaining the wide CF phenotypic variability as an additional control level over the CFTR gene mutations.

1 October 2018 in Patient Preference and Adherence
Verified
Journal Article
Open access
PDF file
CCCarla Colombo
Carla Colombo
PCPaola Catastini
Paola Catastini
ABAnna Brivio
Anna Brivio
BABenedetto Acone
Benedetto Acone
PDPatricia Dang
Patricia Dang
SQSerena Quattrucci
Serena Quattrucci
Purpose: The aim of this study was to determine the level of consensus among Italian health care professionals (HCPs) regarding factors that influence adherence to cystic fibrosis (CF) treatments. Methods: A Delphi questionnaire with 94 statements of potential factors influencing adherence was developed based on a literature review and in consultation with a board of experts (n=4). This was distributed to a multidisciplinary expert panel of HCPs (n=110) from Italian CF centers. A Likert scale was used to indicate the level of agreement (1= no agreement to 9= maximum agreement) with each statement. Three rounds were distributed to establish a consensus (≥80% of participant ratings within one 3-point region) and, at the third round, assign a ranking to each statement with a high level of agreement (consensus in the 7–9 range) only. Results: Of 110 HCPs (from 31 Italian CF centers who were surveyed), responses were obtained from 85 (77%) in the first, 78 (71%) in the second, and 72 (65%) in the third round. The highest degree of agreement (95.8%) was reached with the statement that the HCP needs to build a relationship with the patient to influence adherence. A high level of agreement was not reached for statements that morbidity and mortality are influenced by the level of adherence to therapy, and no consensus was reached on the statement that age of the patient influences adherence to treatment. Conclusion: We found that Italian HCPs endorsed a strong relationship with the patient as being a key driver in improving adherence. There were several areas, such as the influence of adherence on morbidity and mortality, where the consensus of Italian HCPs differed from the published literature. These areas require investigation to determine why these discrepancies exist.

1 August 2003 in Journal of Pediatric Gastroenterology and Nutrition
Verified
Journal Article
Open access
FMFrancesco Morini
Francesco Morini
Denis Andrew CozziDenis Andrew Cozzi
Denis Andrew Cozzi
EBEMANUELE BALDASSARRE
EMANUELE BALDASSARRE
ACAndrea Conforti
Andrea Conforti
SBSandro Bosco
Sandro Bosco
FCFrancesco Cozzi
Francesco Cozzi